Menu
Log in
Forgot password
Log in



Upcoming events

  • Bias: Everyone Has It, Now What?

    • 11/30/2022
    • 1:00 PM - 2:00 PM
    • Zoom
    Register



    Bias: Everyone Has It, Now What? 

     We all have bias. And while it’s incredibly difficult to de-bias brains, it is possible to de-bias systems and organizations. Diversity Lab uses data, behavioral science, and innovation, to shift law firm processes to minimize bias and redesign the advancement and hiring processes through successful initiatives like the Mansfield Rule.


    Join this interactive session and learn to identify where bias shows up in your decision-making processes and what can be done to disrupt bias for long-lasting, inclusive change.

    Earn up to 1.0 Professional CLE for NJ/NY/PA

    Member Free | Non-Member $45.00

    SPEAKERS

    Alyssa Jarvis, Mansfield Rule Manager, Diversity Lab
    Leila Hock, Chief Growth Officer, Diversity Lab

    Zoom Note: Once you register, you will receive a Zoom confirmation e-mail with a unique link to join the session. Click "Add to calendar" to ensure you don't miss the webinar.

    Committee Co-Chairs J. Eric Thies, Organon & Co. and Suja Vathyam, Botos Churchill IP Law LLP

    Show details

  • A Fresh Look at Chemical and Pharmaceutical Selection Inventions: U.S. and European Perspectives

    • 12/20/2022
    • 1:00 PM - 2:00 PM
    • Zoom
    Register


    This webinar intends to provide the background and jurisprudence on the patentability of chemical and pharmaceutical selection inventions. The panel will discuss topics such as novelty, obviousness (or inventive step), and sufficiency of disclosure as it relates to selection inventions and the prior art for which the invention is said to be generically disclosed. Several case examples will be provided and similarities and differences between the US and Europe will be discussed. The discussion will take into account the most recent developments in EPO practice and case law and will review the recent US Federal Circuit decision in Mylan v. Merck.

    Earn up to 1.0 Professional CLE for NJ/NY/PA

    Member Free | Non-Member $45.00

    SPEAKERS

    Dr. Roy Issac, Senior IP Counsel, Bristol Myers Squibb
    Dr. M. David Weingarten, Partner, Finnegan, Henderson, Farabow, Garrett &
    Dunner
    Dr. Steven M. Zeman, European Patent Attorney, Grünecker Patent- und Rechtsanwälte PartG mbB
    Dr. Jegannath Korukottu, European and UK Chartered Patent Attorney, Grünecker Patent- und Rechtsanwälte PartG mbB

    Zoom Note: Once you register, you will receive a Zoom confirmation e-mail with a unique link to join the session. Click "Add to calendar" to ensure you don't miss the webinar.

    Committee Co-Chairs J. Eric Thies, Organon & Co. and Suja Vathyam, Botos Churchill IP Law LLP

    Show details

Past events

11/02/2022 Recent Critical Changes in European and Canadian Patent Practice
09/27/2022 Assignor Estoppel Since the Supreme Court: One Year After Minerva Surgical, Inc. v. Hologic, Inc.
09/20/2022 The Power of Section 337 Investigations
09/13/2022 Recent Case Law Developments Involving Method-of-Treatment Patents
09/06/2022 Forum Shopping and Judge Shopping in Patent Litigation
06/15/2022 38th Annual Joint Patent Practice Seminar
06/10/2022 2022 Jefferson Medal Dinner
03/02/2022 PTAB Judicial Panel
02/23/2022 Ramifications of Arthrex on Practice Before the PTAB
02/16/2022 Latest Trends and Strategic Considerations for Biotech Patent Challenges at the PTAB
02/09/2022 The Interplay Between IPRs and District Court Litigation: Strategies and Lessons
12/15/2021 When Worlds Collide: Patenting Software related to Medical Devices
12/08/2021 Making Your List & Checking It Twice: Considerations for Orange Book Listing in light of Recent Court Decisions
11/03/2021 Embrace the New Changes – Pharmaceutical Patent Protection in China
10/27/2021 Legal Ethics and Telecommuting
07/01/2021 Non-Member: Missed a Webinar? $45 Access to 2021 and 2020 Recordings
06/16/2021 Has Assignor Estoppel outlived its Usefulness?
06/02/2021 2021 Annual Joint Patent Practice CLE Webinar Series
05/26/2021 The Limits of Zealous Representation: Exceptional Case, Patent Misuse, and Antitrust
05/12/2021 How not to be an enabler: The implications of Amgen v. Sanofi and Regeneron for antibody claims and beyond
04/28/2021 Riding the 101 Wave – The Ebb and Flow of Patent Eligibility in the Courts and the PTO
04/14/2021 The requirement for sufficiency: how much is enough to enable claims to a range of products? Recent guidance from the UK Supreme Court in Regeneron v Kymab
03/15/2021 2020 at the Supreme Court: How the court impacted patent law despite issuing only a single patent case opinion
02/17/2021 The Impact of PTAB Proceedings on Bio/Pharma Litigation and Strategy
02/10/2021 Strategies to Leverage Recent PTAB Precedential Decisions
02/03/2021 Amending Patent Claims in PTAB Proceedings
01/27/2021 Examining the Latest Developments on the PTAB’s Use of Discretionary Denials
12/16/2020 Remote at the Federal Circuit, But Central to Pharma: Meeting the Enablement Requirement for Biotech Patents
12/09/2020 Structuring Biotech & Pharma Startup Portfolios for Global Impact, Value, and Partnering
11/18/2020 Professional Responsibility and Practice Before the USPTO
10/07/2020 SPCs in Europe: News and Updates - All You Need to Know
09/30/2020 Presenting Before a District Court: The Importance of Being Earnest
08/25/2020 Recent Developments in Inducement and Divided Infringement
08/11/2020 Diagnosing what Ails Patent Eligibility: Can this Problem be Solved?
07/21/2020 A Behind the Scenes Look at a Supreme Court Argument and a Biotech Jury Trial
07/14/2020 Willful Infringement: Acts of Piracy
06/30/2020 Written Description and Enablement Issues in Pharma/Bio Patents – Latest Developments
06/16/2020 Patent Cases at the Supreme Court: From Petitions to CVSGs to Arguments, and Everything in Between
06/05/2020 2020 Jefferson Medal Dinner
01/23/2020 PTAB Year-in-Review
11/20/2019 33rd Annual Pharmaceutical / Chemical Patent Practice Update
10/28/2019 The Power of Silence: Negotiation Table and Courtroom Survival
09/17/2019 An Overview of Section 337 Investigations Before The U.S. International Trade Commission
06/07/2019 2019 Jefferson Medal Dinner
05/02/2019 Annual Joint Patent Practice Seminar
04/30/2019 Digging Into the Weeds of the Supreme Court’s Funk Brothers Case to Dig Out of 101 Ineligibility?
04/18/2019 Three in One: Global Patent Trials
03/19/2019 Patent Litigation Seminar
12/06/2018 Ethics in IP
11/07/2018 32nd Annual Pharmaceutical / Chemical Patent Practice Update
10/25/2018 Partner Event: The New York Intellectual Property Law Education Foundation 1st Annual Diversity Scholarship Event
06/08/2018 2018 Jefferson Medal Dinner
05/02/2018 Annual Joint Patent Practice Seminar
04/18/2018 NJIPLA & NYIPLA Trade Secrets / Cybersecurity Protecting Your Corporate Client's Information
03/14/2018 Patent Litigation Seminar
11/08/2017 31st Annual Pharmaceutical / Chemical Patent Practice Update
09/18/2017 Blockchain Technology: The Legal Landscape And How It Will Change Everything
06/09/2017 2017 Jefferson Medal Dinner
04/27/2017 Annual Joint Patent Practice Seminar
03/16/2017 Patent Litigation Seminar
02/16/2017 NJIPLA Roundtable: Important IP legal Issues facing Medical Device Companies
12/08/2016 NJIPLA & NYIPLA Joint Program: Ethics Issues in IP Practice
11/02/2016 30th Annual Pharmaceutical / Chemical Patent Practice Update
06/10/2016 2016 Jefferson Medal Dinner
05/11/2016 Screens, Conflicts, and the Ethical Patent Practice
04/21/2016 Thirty-Second Annual Joint Patent Practice Seminar
03/16/2016 Patent Litigation Seminar
01/14/2016 13th Annual Lecture Series
12/02/2015 The New World Order –– Current Developments in Challenging and Defending Patents in the PTAB
11/12/2015 Fifth Annual NJIPLA: Electronics, Telecom & Software Patent Practice Update
10/22/2015 29th Annual Pharmaceutical / Chemical Patent Practice Update
06/05/2015 2015 Jefferson Medal Dinner
05/12/2015 JPPCLE
04/07/2015 IPLS / NJIPLA 2015 Spring Symposium: Meet & Greet
03/18/2015 Patent Litigation Seminar
02/12/2015 Intellectual Property Protection in China From A to Z
12/10/2014 Ethics in IP
11/06/2014 Electronics, Telecom & Software Patent Practice Update
10/22/2014 28th Annual Pharmaceutical / Chemical Patent Practice Update
10/07/2014 12th Annual Fall Lecture Series
09/18/2014 "Recent US Supreme Court Decisions on Patent Law and the Influence on Current Patent Practice and Potential US Patent Law Reform"
06/06/2014 The 2014 Jefferson Medal Dinner
04/23/2014 30th Annual JPPCLE
03/31/2014 Young Lawyers Networking Event
03/12/2014 Patent Litigation Seminar
02/06/2014 Branding and Brand Protection in Digital Media
12/11/2013 27th Annual Pharmaceutical / Chemical Patent Practice Update
11/12/2013 Third Annual Electronics, Telecom and Software Patent Practice Update
09/26/2013 Conducting IP Due Diligence in a Post-AIA Era
05/09/2013 Update on Biopharma IP Issues in Growth Markets: Russia, China, India, Korea and Brazil
03/13/2013 2013 Patent Litigation Seminar
01/24/2013 Second Annual Electronics, Telecom and Software Patent Practice Update
12/05/2012 26th Annual Pharmaceutical / Chemical Patent Practice Update
04/26/2012 Patent Litigation at the ITC
03/14/2012 2012 NJIPLA Patent Litigation Seminar
02/07/2012 The Inside Track to the Proposed Rules for Implementation of the America Invents Act
01/18/2012 Biopharma IP Issues in Emerging Markets: Brazil and India
12/07/2011 25th Annual Pharmaceutical / Chemical Patent Practice Update
11/09/2011 Electronics, Telecom and Software Patent Practice Update
12/08/2010 Chief Patent Counsel Roundtable and Honorable William G. Young's Keynote Address Help Make 24th Annual PCPPU a Success
03/08/2010 Patent Litigation Seminar
12/09/2009 23rd Annual Pharmaceutical / Chemical Patent Practice Update

Tel +1.201.308.8775
E-mail njadmin@njipla.org

New Jersey Intellectual Property Law Association (NJIPLA)